1st EQIPD Newsletter
The first Newsletter by the EQIPD consortium can be found HERE.
The need for quality standards in preclinical research is gaining attention, especially in translational research. The IMI-PainCare consortium has reached out to EQIPD to collaborate in assessing the study design and data analysis for their studies in the BioPain and TRiPP groups. This collaboration will ensure equivalent quality standards in preclinical research among their project…
The Guarantors of EQIPD (GoEQIPD) is a not-for-profit society established to oversee the implementation of the EQIPD Quality System (QS). We are seeking proposals from organisations who wish to work with us in providing mentoring and accreditation to laboratories wishing to meet EQIPD QS standards. Read about the EQIPD QS in our eLife publication Read…
On October 10, 2022, #EQIPD will lead a discussion on how to help funders and grant applicants align on research rigor expectations and avoid funding of research of unknown quality. Objectives of the meeting are to: Review lessons learned from the US and German publicly funded programs that focused directly or indirectly on decision-enabling research…
Hot of the press and we are excited: The EQIPD framework for rigor in the design, conduct, analysis, and documentation of animal experiments. It defines the demands for five domains researchers should be aware of and the needs for them in research design and publications.
We are delighted to announce that Childlight at the University of Edinburgh has successfully achieved the EQIPD certification. The Childlight – Global Child Safety Institute conducts primary research on the situation of children worldwide and develops influential indices that shed light on the realities children face across different regions and contexts. Their work contributes substantially to evidence based policy…
Check out the updates on the outcome of the Alzheimer systematic review, the EQIPD brainstorming session at ECNP, and more in the newest version of our newsletter! Read the Newsletter here.